We are excited to announce that we will be attending the World Orphan Drug Congress USA 2024 in Boston, MA.

We will be conducting a workshop with their partner Trend Community titled "Personalized Endpoints in Clinical Trials: Exploring Goals with AI and Social Listening." 

Our CEO, Chere Chapman, will present how GAS was used as personalized endpoint in Prader Willi Syndrome 

Join us on Pre-conference Day at 15:00

‍